Detalhe da pesquisa
1.
Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom management.
Support Care Cancer
; 29(11): 6505-6510, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33905012
2.
Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura.
J Oncol Pharm Pract
; 26(7): 1695-1702, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32605495
3.
PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma.
Lancet Oncol
; 20(4): e188, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30942175
4.
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia.
Int J Hematol
; 118(6): 682-689, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882977
5.
Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemia.
Leuk Lymphoma
; 63(8): 1839-1848, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35345967
6.
Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia.
Clin Lymphoma Myeloma Leuk
; 21(6): 393-400.e1, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33612433
7.
Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blasts.
Leuk Res
; 103: 106539, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33647818
8.
Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma.
Crit Rev Oncol Hematol
; 148: 102897, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32109715
9.
Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis.
Leuk Lymphoma
; 61(4): 862-868, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31739707